文献速递妇产影像泌尿生殖PETCTMR

68Ga-FAPI PET在卵巢癌评估中的Meta分析

A Meta-analysis of 68Ga-FAPI PET in Assessment of Ovarian Cancer.
PubMed 文献 · Acad Radiol · 2025-03-11

该研究系统检索多个数据库至2024年7月23日,采用双变量随机效应模型汇总68Ga-FAPI PET CT/MR诊断卵巢癌的效能,合并敏感度0.90、特异度0.95;转移性淋巴结和腹膜转移的敏感度分别为0.94和0.93,与18F-FDG PET/CT头对头比较时68Ga-FAPI识别腹膜转移的敏感度更优(P=.0004)。

要点

  • 68Ga-FAPI PET CT/MR诊断卵巢癌合并敏感度0.90(95%CI 0.84-0.95)、特异度0.95(95%CI 0.91-0.97)。
  • 识别转移性淋巴结的合并敏感度0.94(95%CI 0.74-0.99)、特异度0.95(95%CI 0.84-0.99)。
  • 评估腹膜转移的合并敏感度0.93(95%CI 0.81-0.97)、特异度0.96(95%CI 0.89-0.99)。

核心结论

  • 68Ga-FAPI PET CT/MR在卵巢癌中显示出较高的整体诊断效能,在评估卵巢癌腹膜转移时表现出更优的合并敏感度。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Cochrane图书馆和Web of Science数据库,截至2024年7月23日。

诊断标准与关键数值

  • 68Ga-FAPI PET CT/MR诊断卵巢癌的合并敏感度0.90(95%CI 0.84-0.95)、合并特异度0.95(95%CI 0.91-0.97)。
  • 68Ga-FAPI PET CT/MR识别转移性淋巴结的合并敏感度0.94(95%CI 0.74-0.99)、合并特异度0.95(95%CI 0.84-0.99)。
  • 68Ga-FAPI PET CT/MR评估腹膜癌病的合并敏感度0.93(95%CI 0.81-0.97)、合并特异度0.96(95%CI 0.89-0.99)。
  • 与18F-FDG PET/CT头对头比较,68Ga-FAPI PET CT/MR识别腹膜转移的敏感度更优(P=.0004)。

临床应用与阅片要点

  • 原文结论指出68Ga-FAPI PET CT/MR在卵巢癌中整体诊断效能较高,评估腹膜转移时合并敏感度更优。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The objective of this research is to carry out a systematic review and meta-analysis to detect the diagnostic efficacy of 68Ga-FAPI Positron Emission Tomography (PET) Computed Tomography/Magnetic Resonance (CT/MR) in total of the lesions as well as different aspects of metastasis in individuals with ovarian cancers (OC).

MATERIALS AND METHODS: The PubMed, Embase, Cochrane library, and Web of Science databases were thoroughly searched until the cut-off date of July 23, 2024. The assessment of 68Ga-FAPI PET CT/MR of OC was presented by the included studies. Bivariate random effects models were utilized to compute the sensitivity and specificity of 68Ga-FAPI PET CT/MR in OC. The I-square index (I2) was utilized to measure heterogeneity and sensitivity analysis were employed to test it.

RESULTS: The pooled sensitivity as well as specificity for 68Ga-FAPI PET CT/MR in OC were 0.90 (95% CI: 0.84-0.95) as well as 0.95 (95% CI: 0.91-0.97), correspondingly. In the subanalysis for metastatic lesions (lymph node [LN] metastases and peritoneal involvement), the pooled sensitivity and specificity of 68Ga-FAPI PET CT/MR were 0.94 (95% CI: 0.74-0.99) and 0.95 (95% CI: 0.84-0.99) for identifying metastatic LNs as well as 0.93 (95% CI: 0.81-0.97) and 0.96 (95% CI: 0.89-0.99) about peritoneal carcinomatosis evaluation, correspondingly. In the head-to-head comparison with 18F-FDG PET/CT, 68Ga-FAPI PET CT/MR exhibited a better sensitivity in identifying peritoneal metastases (P=.0004).

CONCLUSION: 68Ga-FAPI PET CT/MR displayed a high overall diagnostic effectiveness in OC. When evaluating metastatic peritoneal lesions of OC, 68Ga-FAPI PET CT/MR displayed a superior pooled sensitivity.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Sun L, Zheng L, Zhang B, et al. A Meta-analysis of 68Ga-FAPI PET in Assessment of Ovarian Cancer. Acad Radiol. 2025. PMID: 40074619. doi:10.1016/j.acra.2025.02.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。